Viking Therapeutics (VKTX) Profit After Tax (2016 - 2025)
Historic Profit After Tax for Viking Therapeutics (VKTX) over the last 12 years, with Q3 2025 value amounting to -$90.8 million.
- Viking Therapeutics' Profit After Tax fell 26402.17% to -$90.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$237.4 million, marking a year-over-year decrease of 13942.67%. This contributed to the annual value of -$110.0 million for FY2024, which is 2802.03% down from last year.
- As of Q3 2025, Viking Therapeutics' Profit After Tax stood at -$90.8 million, which was down 26402.17% from -$65.6 million recorded in Q2 2025.
- In the past 5 years, Viking Therapeutics' Profit After Tax ranged from a high of -$12.4 million in Q4 2021 and a low of -$90.8 million during Q3 2025
- In the last 5 years, Viking Therapeutics' Profit After Tax had a median value of -$19.6 million in 2022 and averaged -$27.5 million.
- Per our database at Business Quant, Viking Therapeutics' Profit After Tax crashed by 1028.57% in 2023 and then crashed by 26402.17% in 2025.
- Viking Therapeutics' Profit After Tax (Quarter) stood at -$12.4 million in 2021, then tumbled by 58.3% to -$19.6 million in 2022, then dropped by 25.8% to -$24.6 million in 2023, then crashed by 43.94% to -$35.4 million in 2024, then tumbled by 156.34% to -$90.8 million in 2025.
- Its Profit After Tax was -$90.8 million in Q3 2025, compared to -$65.6 million in Q2 2025 and -$45.6 million in Q1 2025.